Effects of stimulant medication on neuropsychological functioning in college students without ADHD
John M Vasko1, Alison Looby2, Judah Warren Serrano3
1Graduate School of Applied and Professional Psychology, Rutgers University.
Abstract:
Nonmedical prescription stimulant use is prevalent among college students despite no evidence of meaningful neuropsychological improvement in students without attention-deficit/hyperactivity disorder (ADHD). The present study addresses methodological limitations of existing placebo-controlled stimulant administration research by including a within-subject design, baseline comparison, and self-report/subjective measures of neuropsychological functioning to better clarify evidence of cognitive enhancement among college students without ADHD. Participants (n = 21) completed a no-drug baseline session and two counterbalanced experimental sessions that involved ingesting a placebo capsule or an amphetamine-dextroamphetamine immediate release 10 mg capsule. For each session, participants completed objective and self-report/subjective neuropsychological measures. Results indicated no significant differences across sessions for self-report/subjective measures and most objective measures. Specifically, for two outcomes on an objective measure (i.e., continuous performance task-identical pairs), performance improved in either the stimulant and placebo conditions compared to baseline or only the placebo condition compared to baseline. Taken together, the results of this study provide further evidence that stimulant medication does not confer neuropsychological improvement in students without ADHD, and perceived improvements may be better attributed to placebo, rather than pharmacological effects of a stimulant medication for this group. This information can inform ongoing efforts to discourage nonmedical prescription stimulant among college students without ADHD. (PsycInfo Database Record (c) 2026 APA, all rights reserved).
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Stimulants: Psychedelic Agents
